Results 231 to 240 of about 61,679 (338)
Effect of Ranibizumab in Patients with Treatment-Naïve Retinopathy of Prematurity. [PDF]
Khalid H +4 more
europepmc +1 more source
ABSTRACT Background and Aims Hyperglycemia is a known risk factor for retinopathy. With diabetes cases expected to increase from 366 million in 2011 to 552 million by 2030, the global burden of retinopathy may rise. Given this observation, more attention is focused on glycaemic determinants of retinopathy to the neglect of non‐glycaemic factors ...
Moses Banyeh +22 more
wiley +1 more source
Analysis of the incidence and risk factors associated with retinopathy of prematurity in patients complicated by bronchopulmonary dysplasia. [PDF]
Zhang C, He L, Yu M, Sun Z, Sun H.
europepmc +1 more source
M2 macrophages produced and released TREM2‐enriched migrasomes, which were internalized by HRECs through macropinocytosis and phagocytosis. Subsequently, migrasomes up‐regulated pathological retinal angiogenesis and biological functions of HRECs by targeting downstream molecules (BTC, PLA1A, etc).
Bingyan Li +10 more
wiley +1 more source
Construction of a predictive model for retinopathy of prematurity using machine learning algorithms. [PDF]
Yang Y +7 more
europepmc +1 more source
Abstract Background Soybean oil lipid emulsions have been implicated in the development of parenteral nutrition–associated cholestasis (PNAC) in premature infants. A recent mixed fatty acid emulsion containing soybean oil, medium‐chain triglycerides (MCTs), olive oil, and fish oil may reduce the incidence of PNAC, but evidence remains conflicting.
Tian Xie +6 more
wiley +1 more source

